Approval of New Weight-Loss Pill Sparks Changes in US Food Industry
Research indicates that GLP-1 users tend to spend less on salty snacks, baked goods, soft drinks, and alcohol,
WASHINGTON: The approval of a new weight-loss pill in the United States has begun to trigger significant changes in the food industry.
Affordable and easy-to-take GLP-1 pills are becoming more popular than injections, with the number of users expected to rise rapidly.
According to a report by a British news agency, experts predict that from January, the availability of appetite-suppressing GLP-1 weight-loss pills in the US will force food companies to make widespread adjustments to their products. Compared to injections, the cheaper and more convenient pills are likely to attract more users.
Read more: From Medicine to Life — Rediscovering Real Health
Following the US Food and Drug Administration’s approval of Novo Nordisk’s Wegovy pill, shares of food companies fell. Estimates suggest that a competing drug from Eli Lilly will also be approved next year.
Research indicates that GLP-1 users tend to spend less on salty snacks, baked goods, soft drinks, and alcohol, while shifting their diets toward protein- and fiber-rich foods.
Comments are closed, but trackbacks and pingbacks are open.